ACP introduces upgraded decision-making platform, DynaMedex™
DynaMedex provides ACP members with advanced clinical decision support, patient engagement tools, and access to shared decision-making tools, as well as expanded drug information.
DynaMed® is collaborating with ACP to provide free member access to its enhanced decision-making platform that combines the clinical expertise and extensive curated disease content of DynaMed® with the comprehensive drug information and advanced search capabilities of Micromedex®. DynaMedex delivers fast access to information so ACP members can make the best decisions possible at the point of care.
DynaMedex provides ACP members with:
- a mobile app that is available through an iOS App Store or Google Play Store,
- advanced clinical decision support, patient engagement tools, and access to shared decision-making tools with DynaMed Decisions, and personalized alerts, including those that are potentially practice changing,
- drug interaction checker and IV compatibility tool, and comprehensive, trusted adult, pediatric, and neonatal drug information from Micromedex,
- upgraded topic page with a simplified layout and navigation to help users find answers faster,
- natural language chat bot for quick medication answers,
- continuous tracking of CME credits and MOC points through the DynaMedex CME ticker (certificates are stored for easy access) (Baylor College of Medicine Office of Continuing Education is the CME provider), and
- neonatal and pediatric monographs from NeoFax/Pediatrics.
For more information on DynaMedex, visit the ACP website.